Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Diabetes Drug Spurs Weight Loss, But Not Without Side Effects

July 2, 2015 12:30 pm | by Stephanie Guzowski, Editor | News | Comments

The injectable drug liraglutide, marketed as Saxenda, can help overweight or obese patients lose a significant amount of weight — but a study in the New England Journal of Medicine reports that the drug also carries several side effects. Read more...


Researcher Who Faked HIV Vaccine Gets Prison Term, Millions in Fines

July 2, 2015 10:56 am | by Seth Augenstein, Digital Reporter | News | Comments

A scientist who faked results of an experimental HIV vaccine in rabbits to make it appear he had achieved a breakthrough was sentenced to more than 4 years in prison and $7 million in fines by a federal judge, authorities announced. Read more...


The Drunkest Eye: Do Those Baby Blues Mean Higher Rates of Problem Drinking?

July 2, 2015 10:25 am | by Seth Augenstein, Digital Reporter | News | Comments

Blue eyes could be a risk factor for alcohol dependence, according to a new Univ. of Vermont study. People with lighter-colored eyes had a higher incidence of problem drinking, according to the results, published in the American Journal of Medical Genetics Part B. Read more...


Researchers Invent Device That Makes Chemotherapy More Personalized, Efficient

July 2, 2015 10:17 am | by University of Florida | News | Comments

Two University of Florida researchers have invented a device that makes chemotherapy treatments more personalized, efficient and affordable. The miniaturized platform, known as a microarray, uses patients’ cancer cells to test various doses and combinations of chemotherapy drugs. Read more...


Statins Linked to Lower Aggression in Men, But Higher in Women

July 2, 2015 10:11 am | by University of California - San Diego | News | Comments

Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. Read more...


One in Four People Prescribed Opioids Progressed to Longer-Term Prescriptions

July 2, 2015 9:56 am | by Mayo Clinic | News | Comments

Opioid painkiller addiction and accidental overdoses have become far too common across the United States. To try to identify who is most at risk, Mayo Clinic researchers studied how many patients prescribed an opioid painkiller for the first time progressed to long-term prescriptions. Read more...


Alcon Receives European Approval for Pre-Loaded Intraocular Lens Delivery

July 2, 2015 9:28 am | News | Comments

Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ Aspheric IOL with the UltraSertTM Pre-loaded Delivery System for patients undergoing cataract surgery. Read more...

Trends in Antipsychotic Medication Use in Children, Adolescents, and Young Adults

July 2, 2015 9:22 am | by Columbia University | News | Comments

Despite concerns that use of antipsychotic medications in treating young people has increased, use actually declined between 2006 and 2010 for children ages 12 and under, and increased for adolescents and young adults. Read more..


Small, Magnetic Robots Aim to Inject Drugs into the Bloodstream

July 1, 2015 4:38 pm | by Ryan Bushey, Associate Editor | Videos | Comments

The team has been working on a system of “milirobots” that are capable of swimming through a person’s bloodstream or spinal fluid. Read more...


Study Offers Clue to Link Between Swine Flu Shot, Narcolepsy

July 1, 2015 4:21 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

One vaccine used in Europe during the 2009 swine flu pandemic was linked to rare cases of a baffling side effect - the sleep disorder narcolepsy. Now new research offers a clue to what happened. Read more...


Bowel Cancer Risk Reduced by Taking Aspirin for Lynch Syndrome Patients

July 1, 2015 4:09 pm | by University of Melbourne | News | Comments

This is the largest study to date investigating the associations between aspirin, ibuprofen and bowel cancer risk for people with Lynch syndrome. Read more...


Novo Nordisk to Cease Distribution of Tresiba in Germany

July 1, 2015 3:59 pm | News | Comments

The decision to cease distribution of Tresiba in Germany has no implications for the other countries where the product is available. Read more...


Cancer Surgery or Biospy Collection Could Influence Disease Progression

July 1, 2015 3:53 pm | by University of Bristol | News | Comments

Scientists studying the body’s inflammatory response to wounds following cancer surgery or biopsy have found that these procedures may cause growth signals to be delivered to any remaining cancer or pre-cancerous cells which may negatively influence disease progression. Read more...


Recent Drug Approvals will Boost Parkinson's Disease Therapeutics Market

July 1, 2015 3:41 pm | by Heather Leach, Ph.D., Immunology and Neurology Analyst, GlobalData | Articles | Comments

The most promising products are Xadago and Rytary for early and advanced patients, and Acorda’s CVT-301 for advanced patients. Read more...


Stem Cell Gene Therapy Holds Promise for Eliminating HIV Infection

July 1, 2015 10:32 am | by UCLA | News | Comments

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research are one step closer to engineering a tool that could one day arm the body’s immune system to fight HIV — and win. The new technique harnesses the regenerative capacity of stem cells to generate an immune response to the virus. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.